September 27, 2012 — Hologic Inc., a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the women’s healthcare needs, announced today that Rob Cascella, Hologic's president and CEO, will preside over the Oct. 1 NASDAQ Stock Market Opening Bell Ceremony to mark the start of Breast Cancer Awareness Month. This is Hologic's seventh consecutive year of kicking off breast cancer awareness month on NASDAQ. The ceremony will begin at 9:15 a.m. EST.
The NASDAQ Opening Bell Ceremony will be the culmination of a series of events Hologic has planned to raise awareness for its Dimensions 3-D mammography (breast tomosynthesis) system. Unlike conventional 2-D mammography, where the presence of overlapping breast tissue can make it more difficult to detect cancer, the Hologic 3-D mammography procedure allows doctors to see the breast more clearly, particularly for women with dense breasts. As a result, fewer women are called back for additional testing because of false positive results. Clinicians also report that the Hologic 3-D mammography procedure detects cancers that may have been missed by 2-D mammography.
A mobile mammography coach on loan from Baxter Regional Medical Center, the first center in the United States to use 3-D mammography in a mobile setting, will travel from Arkansas to both Washington, D.C., and New York City to demonstrate Hologic's 3-D technology to policy makers, cancer advocates, investors, patients and media.
In his opening remarks at NASDAQ, Cascella will speak about the responsibility of manufacturers to invest in technologies that enable more effective breast cancer screening, and the difference 3-D mammography can make in early detection of the disease. "Hardly a day goes by without a news clip, newspaper article or physician reporting about improved cancer detection using our 3-D technology that would have otherwise been missed," Cascella notes. "Hologic's 3-D technology provides a more detailed, accurate picture of the breast, significantly improving early detection while reducing false positives and unnecessary callbacks by 40 percent. We know the chance for successful treatment is greatest when the cancer is detected early, and hearing so many of these incredible stories strengthens our commitment to make our 3-D mammography technology available to breast centers all over the world."
To emphasize the important role technology plays in the early detection of breast cancer, the mobile coach with the new Hologic Dimensions 3-D mammography system will be positioned in front of the Capitol building in Washington, D.C., on Sept. 25, followed by a trip to the NASDAQ MarketSite in Times Square for the NASDAQ Opening Bell Ceremony on Oct. 1.
Radiologists, clinicians, scientists and developers will be on hand in Washington, D.C., and New York City to answer questions about the breakthrough technology. In addition, the general public will have an opportunity to tour the coach and learn firsthand about new technology for breast cancer screening.
The NASDAQ Stock Market Opening Bell Ceremony will be aired live by clicking on the MarketSite live webcam and will also be aired with closed captioning on the NASDAQ MarketSite Tower in Times Square. A video of the ceremony will be archived for one year on the NASDAQ site.
Hologic's 3-D Mammography System
Hologic's 3-D mammography (breast tomosynthesis) system was approved by the U.S. Food and Drug Administration (FDA) in February 2011. In addition to the more than 300 sites that have a 3-D system in the United States, the technology is installed in hospitals and imaging centers in 26 countries on six continents. The product was approved for sale in Europe and other countries recognizing the CE mark in 2008.
In addition to mammography screening, Hologic provides products and technologies to address the entire continuum of breast health, including screening, definitive diagnosis and therapy. Hologic's breast biopsy systems are designed to provide clinicians with easier and more effective access to lesions with fewer needle insertions. Women diagnosed with early-stage breast cancer may be candidates for Hologic's targeted radiation therapy, a patient-friendly and effective option that can allow women to get back to their normal lives sooner. Hologic's breast magnetic resonance imaging (MRI) solutions are highly sensitive for cancer staging, problem solving, post-treatment surveillance and other indications.
For more information: www.hologic.com
April 15, 2024 
